SEOUL, Sept. 26 (Korea Bizwire) – South Korea’s health authorities said Tuesday they approved the emergency use of Moderna Inc.’s updated COVID-19 vaccine to target today’s most common strain. The approval of the vaccine that targets the XBB.1.5 subvariant came as health authorities have advised people to get free and updated COVID-19 vaccines from Oct. [...]
SEOUL, Sept. 21 (Korea Bizwire) —SK Chemicals is contemplating the potential sale of its pharmaceutical business to Glenwood Private Equity (PE), a private equity fund manager. In response to a disclosure request from the Korea Exchange regarding Glenwood PE’s proposed acquisition of SK Chemicals’ pharmaceutical business unit, SK Chemicals stated, “We are in the process [...]
SEOUL, Aug. 25 (Korea Bizwire) — South Korea’s major pharmaceutical firm Celltrion Inc. said Friday it has completed a license deal with Johnson & Johnson to sell its autoimmune disease treatment biosimilar in the United States. The deal will allow Celltrion’s CT-P43, the company’s ustekinumab biosimilar referencing Stelara, developed by J&J’s pharmaceutical unit of Janssen [...]
SEOUL, Aug. 25 (Korea Bizwire) — POSCO International Corp., the trading arm of South Korean steel giant POSCO Holdings Co., said Thursday it exported a swine pneumonia vaccine to National Veterinary Joint Stock Co. (NAVETCO), Vietnam’s premier animal vaccine enterprise, marking its maiden venture into the realm of animal vaccine exportation. This achievement is the [...]
SEOUL, Aug. 24 (Korea Bizwire) — SK bioscience Co. said Thursday it has reached a deal with Vaxxas, an Australian biotechnology company, to jointly develop a new patch-type typhoid vaccine. The global charitable foundation Wellcome will fund the collaboration for the first two years, awarding US$3.67 million to conduct the first-phase clinical trial, according to [...]
SEOUL, Aug. 23 (Korea Bizwire) — SK bioscience Co., a pharmaceutical affiliate under South Korea’s SK Group, said Wednesday it will produce 5 million doses of its signature cell-based influenza vaccine SKYCellflu nationwide from next month for the coming winter season. It resumed the production two years after it had stopped manufacturing the prefilled syringe-typed [...]
SEOUL, Aug. 18 (Korea Bizwire) – SK Biopharmaceuticals Co., a pharmaceutical affiliate of South Korea’s SK Group, said Friday it has reached a license and commercialization deal with the Middle East unit of British drugmaker Hikma Pharmaceuticals Plc. Under the deal, Hikma MENA FZE is granted an exclusive license to develop and commercialize the Korean [...]
SEOUL, Aug. 17 (Korea Bizwire) — South Korea’s major pharmaceutical firm Cellltrion Inc. said Thursday it will merge with its sales and marketing affiliate Celltrion Healthcare Co. in a bid to become a global drugmaker by streamlining its key operational structure. The company said in a regulatory filing that the merger is aimed at growing [...]
SEOUL, Aug. 14 (Korea Bizwire) — South Korean pharmaceutical companies, currently involved in developing drugs for diabetes and obesity, are emphasizing the improvement of usage convenience by extending drug efficacy durations and modifying formulations. Peptron Inc. is progressing toward transferring PT404, a sustained-release diabetes and obesity treatment formulation, to global pharmaceutical firms. Unlike existing treatments [...]
SEOUL, Aug. 13 (Korea Bizwire) — Hyundai Bioscience Co. said Sunday it will develop a broad-spectrum antiviral drug with the U.S. National Institutes of Health (NIH), a federal agency for conducting and supporting medical research. Hyundai Bioscience USA, a wholly owned subsidiary of Hyundai Bioscience Co., signed a Non-Clinical Evaluation Agreement (NCEA) with the National [...]